Corporations prepared to profit at patients’ expense By Ted Smith Dramatic changes to the Canadian medical cannabis scene are on the horizon. Patients are about to collectively suffer when the new Marijuana for Medical Purposes Regulations replace the Marijuana Medical Access Regulations. Commercial producers are eager to attract venture capitalists to make a lot of […]
By Owen Smith Through failed attempts to manipulate cannabinoids or their partner receptor system in our body, pharmaceutical companies have learned some valuable lessons about the whole plant synergy of cannabis medicine. The complex chemistry of the cannabis plant is intimately connected to the complex processes and transformations that occur in our bodies’ endocannabinoid system […]
